|
Volumn 23, Issue 26, 2004, Pages 4556-4566
|
Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer
|
Author keywords
Breast cancer; HIN 200; IFIX; Interferon; p21CIPI
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLIN DEPENDENT KINASE INHIBITOR;
GAMMA INTERFERON INDUCIBLE PROTEIN 10;
GAMMA INTERFERON INDUCIBLE PROTEIN 10 ALPHA1;
GAMMA INTERFERON INDUCIBLE PROTEIN 10 ALPHA2;
GAMMA INTERFERON INDUCIBLE PROTEIN 10 BETA1;
GAMMA INTERFERON INDUCIBLE PROTEIN 10 BETA2;
GAMMA INTERFERON INDUCIBLE PROTEIN 10 GAMMA1;
GAMMA INTERFERON INDUCIBLE PROTEIN 10 GAMMA2;
ISOPROTEIN;
LIPOSOME;
PROTEIN KINASE;
PROTEIN P21;
UNCLASSIFIED DRUG;
CDK2 PROTEIN, HUMAN;
CDK2 PROTEIN, MOUSE;
CDKN1A PROTEIN, HUMAN;
CDKN1A PROTEIN, MOUSE;
CYCLIN DEPENDENT KINASE;
CYCLIN DEPENDENT KINASE 1;
CYCLIN DEPENDENT KINASE 2;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
HIN 200 PROTEIN, HUMAN;
HIN 200 PROTEIN, MOUSE;
HIN-200 PROTEIN, HUMAN;
HIN-200 PROTEIN, MOUSE;
IFIX PROTEIN, HUMAN;
NUCLEAR PROTEIN;
PROTEIN P53;
RETINOBLASTOMA PROTEIN;
AMINO ACID SEQUENCE;
AMINO TERMINAL SEQUENCE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER CELL CULTURE;
CONTROLLED STUDY;
DRUG SCREENING;
GENE TRANSFER;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
INTERFERON INDUCTION;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
RNA SPLICING;
ALTERNATIVE RNA SPLICING;
ANIMAL;
BREAST TUMOR;
CARCINOGEN TESTING;
CELL CULTURE;
FEMALE;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETICS;
METABOLISM;
METHODOLOGY;
MOLECULAR GENETICS;
MOUSE;
NUDE MOUSE;
MUS MUSCULUS;
ALTERNATIVE SPLICING;
AMINO ACID SEQUENCE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CARCINOGENICITY TESTS;
CDC2 PROTEIN KINASE;
CDC2-CDC28 KINASES;
CYCLIN-DEPENDENT KINASE 2;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE THERAPY;
HUMANS;
MICE;
MICE, NUDE;
MOLECULAR SEQUENCE DATA;
NUCLEAR PROTEINS;
PROTEIN ISOFORMS;
RETINOBLASTOMA PROTEIN;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 3042621022
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1207592 Document Type: Article |
Times cited : (59)
|
References (39)
|